125 related articles for article (PubMed ID: 29111580)
1. Drug residues in used syringes in Switzerland: A comparative study.
Lefrançois E; Augsburger M; Esseiva P
Drug Test Anal; 2018 May; 10(5):874-879. PubMed ID: 29111580
[TBL] [Abstract][Full Text] [Related]
2. Analysis of residual content of used syringes collected from low threshold facilities in Lausanne, Switzerland.
Lefrançois E; Esseiva P; Gervasoni JP; Lucia S; Zobel F; Augsburger M
Forensic Sci Int; 2016 Sep; 266():534-540. PubMed ID: 27514014
[TBL] [Abstract][Full Text] [Related]
3. Drug analysis of residual content of used syringes: a new approach for improving knowledge of injected drugs and drug user practices.
Néfau T; Charpentier E; Elyasmino N; Duplessy-Garson C; Levi Y; Karolak S
Int J Drug Policy; 2015 Apr; 26(4):412-9. PubMed ID: 25449054
[TBL] [Abstract][Full Text] [Related]
4. Substances injected at the Sydney supervised injecting facility: A chemical analysis of used injecting equipment and comparison with self-reported drug type.
Lefrancois E; Belackova V; Silins E; Latimer J; Jauncey M; Shimmon R; Mozaner Bordin D; Augsburger M; Esseiva P; Roux C; Morelato M
Drug Alcohol Depend; 2020 Apr; 209():107909. PubMed ID: 32145660
[TBL] [Abstract][Full Text] [Related]
5. Substances detected in used syringes of injecting drug users across 7 cities in Europe in 2017 and 2018: The European Syringe Collection and Analysis Project Enterprise (ESCAPE).
Brunt TM; Lefrançois E; Gunnar T; Arponen A; Seyler T; Goudriaan AE; McAuley A; McKeown DA; Detrez V; Csorba J; Deimel D; Auwärter V; Kempf J; Karolak S; Nefau T
Int J Drug Policy; 2021 Sep; 95():103130. PubMed ID: 33487529
[TBL] [Abstract][Full Text] [Related]
6. Analytical findings in used syringes from a syringe exchange program.
Fiorentin TR; Logan BK
Int J Drug Policy; 2020 Jul; 81():102770. PubMed ID: 32442881
[TBL] [Abstract][Full Text] [Related]
7. Which illicit drugs are injected in Oslo? A study based on analysis of drug residues in used injection equipment and self-reported information.
Gjerde H; Bretteville-Jensen AL; Bache-Andreassen L; Hanoa K; Furuhaugen H; Brochmann GW; Vindenes V
Scand J Public Health; 2023 Feb; 51(1):21-27. PubMed ID: 34538164
[TBL] [Abstract][Full Text] [Related]
8. A snapshot of injecting drug consumption from the analysis of used syringes within the Medically Supervised Injecting Centre in Sydney, Australia.
Fursman H; Finch E; Xiao L; Lefrançois E; Gupta A; Bartlett M; Latimer J; Chadwick S; Roux C; Morelato M
Drug Alcohol Rev; 2024 Mar; 43(3):787-798. PubMed ID: 38145366
[TBL] [Abstract][Full Text] [Related]
9. Pattern of injecting drug uses and HIV-1 infection: analysis from needle exchange program.
Tellado I; Moran N; Vargas Vidot J; Yamamura Y
Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):1091-6. PubMed ID: 9449543
[TBL] [Abstract][Full Text] [Related]
10. Solid phase microextraction and gas chromatography-mass spectrometry methods for residual solvent assessment in seized cocaine and heroin.
Cabarcos P; Herbello-Hermelo P; Álvarez-Freire I; Moreda-Piñeiro A; Tabernero MJ; Bermejo AM; Bermejo-Barrera P
Anal Bioanal Chem; 2016 Sep; 408(23):6393-402. PubMed ID: 27405875
[TBL] [Abstract][Full Text] [Related]
11. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
Emmanuelli J; Desenclos JC
Addiction; 2005 Nov; 100(11):1690-700. PubMed ID: 16277629
[TBL] [Abstract][Full Text] [Related]
12. Cocaine and heroin in waste water plants: a 1-year study in the city of Florence, Italy.
Mari F; Politi L; Biggeri A; Accetta G; Trignano C; Di Padua M; Bertol E
Forensic Sci Int; 2009 Aug; 189(1-3):88-92. PubMed ID: 19467810
[TBL] [Abstract][Full Text] [Related]
13. Qualitative, quantitative and temporal study of cutting agents for cocaine and heroin over 9 years.
Broséus J; Gentile N; Bonadio Pont F; Garcia Gongora JM; Gasté L; Esseiva P
Forensic Sci Int; 2015 Dec; 257():307-313. PubMed ID: 26448535
[TBL] [Abstract][Full Text] [Related]
14. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
[TBL] [Abstract][Full Text] [Related]
15. Displacement of Canada's largest public illicit drug market in response to a police crackdown.
Wood E; Spittal PM; Small W; Kerr T; Li K; Hogg RS; Tyndall MW; Montaner JS; Schechter MT
CMAJ; 2004 May; 170(10):1551-6. PubMed ID: 15136548
[TBL] [Abstract][Full Text] [Related]
16. The role of illicit, licit, and designer drugs in the traffic in Hungary.
Institóris L; Hidvégi E; Dobos A; Sija É; Kereszty ÉM; Tajti LB; Somogyi GP; Varga T
Forensic Sci Int; 2017 Jun; 275():234-241. PubMed ID: 28412575
[TBL] [Abstract][Full Text] [Related]
17. Analysis of drug residue in needle-exchange syringes in Washington, D.C.
Evans A; Krause M; Leach S; Levitas M; Nguyen L; Short LC
Forensic Sci Int; 2021 Dec; 329():111083. PubMed ID: 34741990
[TBL] [Abstract][Full Text] [Related]
18. Illicit drug abuse in the Marmara region of Turkey.
Atasoy S; Biçer F; Açikkol M; Bilgiç Z
Forensic Sci Int; 1988; 38(1-2):75-81. PubMed ID: 3192137
[TBL] [Abstract][Full Text] [Related]
19. Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project.
Brunt TM; Nagy C; Bücheli A; Martins D; Ugarte M; Beduwe C; Ventura Vilamala M
Drug Test Anal; 2017 Feb; 9(2):188-198. PubMed ID: 26888408
[TBL] [Abstract][Full Text] [Related]
20. [Accumulation and stability of drugs in hair].
Balabanova S; Albert W
Arch Kriminol; 1994; 193(3-4):100-12. PubMed ID: 8198430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
